Eric Stec,Ming F. Pomerleau,Rick T. Owens,Richard Seeman
申请号：
US15882374
公开号：
US20180214520A1
申请日:
2018.01.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present application relates to use of transglutaminases to treat various tissue matrix products. The methods can include application of a transglutaminase to a partially denatured collagen-containing tissue matrix and implantation of the tissue matrix. The transglutaminase can facilitate adhesion with another collagen-containing tissue matrix, tissue surrounding the tissue matrix after implantation, or both.
